Dimensional Fund Advisors LP
- SEC CIK
- 0000354204
- Latest filing
- Aug 11, 2026
ORMP holding history
Oramed Pharmaceuticals Inc. in every 13F filed by Dimensional Fund Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ORMP overviewAll 13F holders of ORMPFull Q2 2026 holdings
- Shares (Q2 2026)
- 202,609
- Value
- $973.8K
- % of portfolio
- <0.1%
- Quarters held
- 11
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 202,609 | $973.8K | <0.1% | +44,400+28.1% | Added | Holders |
| Q1 2026 | 158,209 | $537.7K | <0.1% | +7,738+5.1% | Added | Holders |
| Q4 2025 | 150,471 | $428.8K | <0.1% | +2,984+2.0% | Added | Holders |
| Q3 2025 | 147,487 | $389.4K | <0.1% | −19,412−11.6% | Reduced | Holders |
| Q2 2025 | 166,899 | $375.5K | <0.1% | +25,818+18.3% | Added | Holders |
| Q1 2025 | 141,081 | $301.9K | <0.1% | +22,086+18.6% | Added | Holders |
| Q4 2024 | 118,995 | $288.0K | <0.1% | +70,190+143.8% | Added | Holders |
| Q3 2024 | 48,805 | $119.1K | <0.1% | +17,335+55.1% | Added | Holders |
| Q2 2024 | 31,470 | $80.9K | <0.1% | +10,774+52.1% | Added | Holders |
| Q1 2024 | 20,696 | $60.4K | <0.1% | +20,696 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −27,285−100.0% | Sold out | Holders |
| Q3 2023 | 27,285 | $71.2K | <0.1% | +27,285 | New | Holders |